TerrAscend (OTCMKTS:TSNDF) Issues Quarterly Earnings Results, Misses Expectations By $0.02 EPS

TerrAscend (OTCMKTS:TSNDF - Get Free Report) posted its quarterly earnings results on Thursday. The company reported ($0.05) EPS for the quarter, missing analysts' consensus estimates of ($0.03) by ($0.02), Zacks reports. The firm had revenue of $71.00 million during the quarter, compared to analyst estimates of $71.63 million. TerrAscend had a negative return on equity of 31.48% and a negative net margin of 23.95%.

TerrAscend Stock Up 0.1%

OTCMKTS:TSNDF traded up $0.00 during mid-day trading on Friday, reaching $0.38. The stock had a trading volume of 934,619 shares, compared to its average volume of 690,723. The company has a market capitalization of $109.74 million, a price-to-earnings ratio of -1.39 and a beta of 1.55. TerrAscend has a 1-year low of $0.23 and a 1-year high of $1.94. The stock's 50 day simple moving average is $0.38 and its two-hundred day simple moving average is $0.58. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.35 and a quick ratio of 0.69.

TerrAscend Company Profile

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names.